2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,874,320 | -52.8% | 1,243,449 | +21.8% | 0.01% | -50.0% |
| Q2 2023 | $10,332,044 | -0.5% | 1,020,953 | +0.3% | 0.01% | 0.0% |
| Q1 2023 | $10,383,336 | +10.1% | 1,017,974 | +1.1% | 0.01% | 0.0% |
| Q4 2022 | $9,433,182 | -35.5% | 1,006,743 | +0.1% | 0.01% | -37.5% |
| Q3 2022 | $14,633,000 | +10.2% | 1,005,750 | -0.1% | 0.02% | +14.3% |
| Q2 2022 | $13,284,000 | -22.5% | 1,006,362 | +0.2% | 0.01% | -6.7% |
| Q1 2022 | $17,134,000 | -19.8% | 1,004,372 | +20.5% | 0.02% | +36.4% |
| Q4 2021 | $21,362,000 | – | 833,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |